Literature DB >> 22986012

The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.

Aurélie Jeanne Tormo1, Marie-Claude Letellier, Rami Lissilaa, Laurie-Anne Batraville, Mukut Sharma, Walter Ferlin, Greg Elson, Sandrine Crabé, Jean-François Gauchat.   

Abstract

Ciliary neurotrophic factor (CNTF) and cardiotrophin-like cytokine (CLC) are two cytokines with neurotrophic and immunomodulatory activities. CNTF is a cytoplasmic factor believed to be released upon cellular damage, while CLC requires interaction with a soluble cytokine receptor, cytokine-like factor 1 (CLF), to be efficiently secreted. Both cytokines activate a receptor complex comprising the cytokine binding CNTF receptor α (CNTFRα) and two signaling chains namely, leukemia inhibitory factor receptor β (LIFRβ) and gp130. Human CNTF can recruit and activate an alternative receptor in which CNTFRα is substituted by IL-6Rα. As both CNTF and CLC have immune-regulatory activities in mice, we compared their ability to recruit mouse receptors comprising both gp130 and LIFRβ signaling chains and either IL-6Rα or IL-11Rα which, unlike CNTFRα, are expressed by immune cells. Our results indicate that 1) mouse CNTF, like its human homologue, can activate cells expressing gp130/LIFRβ with either CNTFRα or IL-6Rα and, 2) CLC/CLF is more restricted in its specificity in that it activates only the tripartite CNTFR. Several gp130 signaling cytokines influence T helper cell differentiation. We therefore investigated the effect of CNTF on CD4 T cell cytokine production. We observed that CNTF increased the number of IFN-γ producing CD4 T cells. As IFN-γ is considered a mediator of the therapeutic effect of IFN-β in multiple sclerosis, induction of IFN-γ by CNTF may contribute to the beneficial immunomodulatory effect of CNTF in mouse multiple sclerosis models. Together, our results indicate that CNTF activates the same tripartite receptors in mouse and human cells and further validate rodent models for pre-clinical investigation of CNTF and CNTF derivatives. Furthermore, CNTF and CLC/CLF differ in their receptor specificities. The receptor α chain involved in the immunomodulatory effects of CLC/CLF remains to be identified. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986012     DOI: 10.1016/j.cyto.2012.08.014

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.

Authors:  Jun W Kim; Cesar P Marquez; R Andres Parra Sperberg; Jiaxiang Wu; Won G Bae; Po-Ssu Huang; E Alejandro Sweet-Cordero; Jennifer R Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-10       Impact factor: 11.205

2.  Cardiotrophin-like cytokine (CLCF1) modulates mesenchymal stem cell osteoblastic differentiation.

Authors:  Sarah Nahlé; Sarah Pasquin; Véronique Laplante; François Rousseau; Mukut Sharma; Jean-François Gauchat
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

3.  The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR).

Authors:  Eva-Maria Wagener; Matthias Aurich; Samadhi Aparicio-Siegmund; Doreen M Floss; Christoph Garbers; Kati Breusing; Björn Rabe; Ralf Schwanbeck; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

4.  The IL-27 component EBI-3 and its receptor subunit IL-27Rα are essential for the cytoprotective action of humanin on male germ cells†.

Authors:  Yue Jia; Ronald S Swerdloff; YanHe Lue; Jenny Dai-Ju; Prasanth Surampudi; Pinchas Cohen; Christina Wang
Journal:  Biol Reprod       Date:  2021-03-11       Impact factor: 4.161

5.  Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family.

Authors:  Virginia J Savin; Mukut Sharma; Jianping Zhou; David Gennochi; Timothy Fields; Ram Sharma; Ellen T McCarthy; Tarak Srivastava; Jos Domen; Aurélie Tormo; Jean-François Gauchat
Journal:  J Immunol Res       Date:  2015-06-04       Impact factor: 4.818

Review 6.  Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family.

Authors:  Hideaki Hasegawa; Izuru Mizoguchi; Yukino Chiba; Mio Ohashi; Mingli Xu; Takayuki Yoshimoto
Journal:  Front Immunol       Date:  2016-11-04       Impact factor: 7.561

Review 7.  Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.

Authors:  Virginia J Savin; Mukut Sharma; Jianping Zhou; David Genochi; Ram Sharma; Tarak Srivastava; Amna Ilahe; Pooja Budhiraja; Aditi Gupta; Ellen T McCarthy
Journal:  Biomed Res Int       Date:  2017-08-10       Impact factor: 3.411

8.  Effect of human very low-density lipoproteins on cardiotrophin-like cytokine factor 1 (CLCF1) activity.

Authors:  Sarah Pasquin; Salma Chehboun; Agnieszka Dejda; Yasmine Meliani; Virginia Savin; Gregory J Warner; Roger Bosse; Aurélie Tormo; Gaétan Mayer; Mukut Sharma; Przemyslaw Sapieha; Catherine Martel; Jean-François Gauchat
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

9.  Chemically extracted acellular allogeneic nerve graft combined with ciliary neurotrophic factor promotes sciatic nerve repair.

Authors:  Yanru Zhang; Hui Zhang; Kaka Katiella; Wenhua Huang
Journal:  Neural Regen Res       Date:  2014-07-15       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.